Experimental Autoimmune Uveitis (EAU) induced by retinal antigens, particularly S-antigen, forms a useful model of human chronic intraocular inflammation particularly endogenous post erior uveitis. It provides a means of assessing the efficacy of various agents used in the control of such inflammation. We induced an autoimmune uveitis and its associated pinealitis in Dun kin-Hartley guinea pigs and Lewis rats by inoculating them with bovine retinal S-antigen. In rats, induction of EAU but not of Experimental Autoimmune Pinealitis (EAP) could be pre vented by the administration of S-antigen specific rat monoclonal antibody simultaneously with the S-antigen. Inhibition of EAU was accompanied by significantly raised levels of anti-S antibodies during the first two weeks post-immunisation. In contrast, the same monoclonal antibody failed to inhibit both EAU and EAP in guinea pigs. Immunocytochemical staining of rat tissues for lymphocyte subsets, monocytes and macrophages showed that eyes of monoc lonal antibody treated animals contained no immunocompetent inflammatory cells unless they also had clinical signs of inflammation. In contrast, the inflammatory exudate in the pineal glands of both treated and untreated animals contained equal numbers of infiltrating lympho cytes and monocytes in the same relative proportions. These results indicate that the inhibitory effect of the monoclonal antibody S2.4.CS is directed towards the effector arm of the immune mediated cytotoxic response. A possible mechanism by which the antibody may be preferen tially inhibiting the inflammatory response in the eyes but not in the pineal glands of rats, is suggested.
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Summary
Experimental Autoimmune Uveitis (EAU) induced by retinal antigens, particularly S-antigen, forms a useful model of human chronic intraocular inflammation particularly endogenous post erior uveitis. It provides a means of assessing the efficacy of various agents used in the control of such inflammation. We induced an autoimmune uveitis and its associated pinealitis in Dun kin-Hartley guinea pigs and Lewis rats by inoculating them with bovine retinal S-antigen. In rats, induction of EAU but not of Experimental Autoimmune Pinealitis (EAP) could be pre vented by the administration of S-antigen specific rat monoclonal antibody simultaneously with the S-antigen. Inhibition of EAU was accompanied by significantly raised levels of anti-S antibodies during the first two weeks post-immunisation. In contrast, the same monoclonal antibody failed to inhibit both EAU and EAP in guinea pigs. Immunocytochemical staining of rat tissues for lymphocyte subsets, monocytes and macrophages showed that eyes of monoc lonal antibody treated animals contained no immunocompetent inflammatory cells unless they also had clinical signs of inflammation. In contrast, the inflammatory exudate in the pineal glands of both treated and untreated animals contained equal numbers of infiltrating lympho cytes and monocytes in the same relative proportions. These results indicate that the inhibitory effect of the monoclonal antibody S2. 4 .CS is directed towards the effector arm of the immune mediated cytotoxic response. A possible mechanism by which the antibody may be preferen tially inhibiting the inflammatory response in the eyes but not in the pineal glands of rats, is suggested.
Chronic intraocular inflammation is an important cause of ocular morbidity and vis ual loss particularly among young adults. Several exogenous and endogenous factors have been identified in the <etiology of such inflammation. 1 However, in spite of intensive investigation, specific <etiological agent(s) have rarely been demonstrated, and associa tions with other systemic diseases have been shown in only 50% of cases.2-4 A large prop ortion of these cases present evidence of an immunological disturbance indicating that immune mechanisms are involved in initiat ing and/or establishing the chronicity of the disease and its tendency to recur. [5] [6] [7] [8] [9] Experi mental autoimmune uveitis (EAU) induced by retinal antigens, particularly S-antigen is a useful animal model of chronic intraocular inflammation. Besides uveitis, S-antigen in duces an inflammatory reaction in the pineal gland thereby demonstrating another link between the pineal gland and the eye. Hl-12 EAU has been used extensively in studying the <etiopathogenesis and pathology of chronic uveitis.13-18 It also provides a means of testing therapeutic agents and regimes that may be of value in the management of human uveitis. Immunomodulation of EAU using monoclonal antibodies to stimulate anti idiotypic antibodies is currently receiving much attention.19-21 De Kozak et al19 showed that the induction of EAU could be inhibited by the administration of an S-antigen specific monoclonal antibody simultaneously with the S-antigen. They used a mouse anti-S monoc lonal antibody in Lewis rats. In this heterologous syste�, it was suggested that the immunogenic and uveitogenic effects of S-antigen were inhibited via induction of anti-idiotypic responses. In the present study we used a rat anti-S monoclonal antibody, S2.4.C5,22 and tested its effect on EAU in (a) a heterologous system using Dunkin Hartley guinea pigs and (b) a homologous system using Lewis rats. We also studied the effect of the monoclonal antibody on experimental autoimmune pinealitis (EAP) in both these groups of animals. A possible mechanism of action of the monclonal antibody, other than by invoking an anti-idiotypic response, is suggested.
Material and Methods
Ani';wls: The initial study was conducted in guinea pigs. Nine Dunkin-Hartley guinea pigs (weighing 600 -800 grams each) were subdivided into a test group of five animals (Group 1) that received the monoclonal anti body plus antigen and a control group of four animals (Group 2) that received the S-anti gen alone. In the second experiment, twenty two female Lewis rats (180 to 250 grams each) were subdivided into three groups all of whom were immunised with retinal S-anti gen. A test group of ten animals (Group 1) also received the monoclonal antibody. One control group of six animals received no further therapy (Group 2) while the second control group was inoculated with a non specific rat IgG in addition to the S-antigen (Group 3).
Retinal S-antigen: Bovine retinal S-antigen was prepared as previously described23 except that the final purification of antigen was performed by high performance liquid chromatography on a TSK-DEAE column. The antigen purity was demonstrated as a single homogeneous band by silver staining on SDS polyacrylamide gel using the Phar macia Phast system according to the man ufacturer's instructions.
MC/noclonal antibody to bovine S-antigen: A rat cell-line, S2.4.C5, was used to produce monoclonal antibody to bovine S-antigen.22 Antibody was collected as cell supernatant and purified using established methods on QEAE Sephadex. Some samples were further purified by affinity chromatography on Protein-A Sepharose, and shown to con tain over 99% IgG by SDS-PAGE (Phar macia Phast system).
Immunisation protocol: Eyes of all animals were examined by slit lamp biomicroscopy prior to immunisation to exclude any pre existing pathology. The animals were then immunised as described in Table I . Rats were tail bled after inoculation, and serum was stored at -70°C.
Clinical observation: All animals in both experiments were observed from day one post-inoculation. Clinical examination of the eyes with the slit lamp and direct ophthal moscope was carried out after dilation of pupils with 1% cyclopentolate. The day of onset of uveitis, its severity and its course were noted. The severity of the inflammatory activity was graded on a scale of 0 -4 as described by Forrester et al.l7 Rats were tail bled at weekly intervals until sacrificed and serum stored at -70°C.
Sample preparation: Guinea pigs were sac rificed on days 22123 post-inoculation. Both eyes and the pineal gland were obtained for examination. One eye was snap frozen in Tis sue-TEK, OCT compound (Miles Scientific) by immersing in liquid arcton near its freez ing point. The other eye was fixed in 3% phosphate buffered glutaraldehyde and pro cessed for electron and light microscopy. The pineal gland was fixed in acetic formal,saline and processed for light microscopy. Rats were sacrificed at various time inter vals, mostly around the peak of the inflam matory activity or soon thereafter. Animals that did not show any clinical disease were killed 28 to 30 days post-immunisation. Blood samples were collected and both eyes and the pineal gland were obtained for examination. One eye from each animal and half of the pineal glands from each group were snap frozen. The other eye and the remaining pineal glands were fixed in 3% phosphate buffered glutaraldehyde and pro� cessed for electron and light microscopy.
Immunocytochemistry:
Lymphocyte sub populations were tested in inflammatory lesions in rat eyes using a panel of monoc lonal antibodies (Table II) . Frozen sections on chrome-alum gelatin coated glass slides were stained by hematoxylin and eosin and also by the immunocytochemical Alkaline Phosphatase Anti-Alkaline Phosphatase (AP AAP) technique. Rabbit anti-mouse immunoglobulin (Dakopatts) was used as the secondary antibody and APAAP (mouse) complexes (Dakopatts) as the tertiary anti body. Semi-thin sections of glutaraldehyde fixed tissues, stained with toluidine blue and basic fuschin, were also used for his topathological study.
Antibodies to Retinal S-antigen: Antibody titres to retinal S-antigen were estimated using a standard ELISA technique24 mod ified for rat serum. Microtiter 96 well plates were coated with bovine S-antigen (1 microg ram/ml in 0.02M Tris/HCI buffer, pH9), blocked with 0.5% bovine serum albumin, then incubated with the test sera. Bound antibodies were detected using peroxidase conjugated rabbit anti-rat immunogloblins (Dakopatts).
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Results
Guinea Pigs
Clinical: All five guinea pigs in Group 1 (monoclonal antibody plus S-antigen) had signs of uveitis by day 10 and by day 12 the uveitis had reached its peak (4+). All four guinea pigs in Group 2 (S-antigen alone) had signs of uveitis on day 12 and the severity of inflammation had reached its maximum (4+) by day 14 (Table III) . At the peak of the inflammatory response the eyes showed con gestion, corneal haze, cells and flare in the anterior chamber, hyperaemia of the iris, haemorrhagic retro-iridial hypopyon and vitreous exudate obscuring retinal details.
Ocular pathology: Eyes from all guinea pigs, both treated and untreated with S2.4.C5 showed similar features on histol ogy. The lesions within an eye ranged from early inflammatory infiltration in the choroid with some disruption of the subjacent photo receptor layer (Fig. la) to massive infiltration of the entire chorioretina, optic nerve, ciliary body and iris (Fig. Ib) . The choroid was thic kened with inflammatory cells, chiefly lym phocytes, monocytes, polymorphonuclear leukocytes and macrophages. The retinal pig ment epithelium was disrupted at places with loss of the photoreceptor layer. The retina showed serous detachment at places with a predpminance of neutrophils and monocytes in the exudate. At other places the retinal architecture was totally disorganised making it impossible to distinguish the various layers.
Pineal inflammation: The pineal glands of all animals in both groups showed massive mononuclear infiltration. In some glands it was largely confined to the subcapsular zone but in most it was uniformly spread through out the substance of the gland (Fig. lc) dis rupting the normal architecture (Fig. Id) . In contrast to the ocular inflammation the pineal inflammatory response was predomin antly lymphocytic with an absence of polymorphonuclear cells.
Rats
Clinical: Five of the six control animals (Group 2, immunised with S-antigen alone) developed a severe early onset uveitis involv ing the anterior and posterior segments of both eyes. Clinically this was manifest as a hypopyon uveitis with obscuration of the fun dal view at its peak of inflammation. Simi larly, five of the six rats immunised with S antigen and non-specific IgG (Group 3) developed a marked uveitic response although this was slightly reduced in severity with a later onset. In contrast, only two of ten rats that were immunised with S-antigen and the rat monoclonal antibody S2.4.C5 developed uveitis, in each case uveitis was also delayed in onset and of least severity.
Ocular pathology: Eyes from S-antigen immunised rats treated with the monoclonal antibody S2.4.C5 which were clinically not inflaIll ed (80% ) showed no evidence of inflammatory cell infiltration (Fig. 2a) . In contrast, eyes from untreated rats or rats treated with non-specific IgG demonstrated multiple focal inflammatory lesions which varied in severity from perivasculitis with early round cell infiltration in the photo receptor layer (Fig. 2b) to extensive granulomatous infiltration of the retina and choroid with loss of photoreceptor cells ( sent in all three groups of S-antigen immunised rats whether untreated or treated with either rat IgG or the monoclonal anti body S2.4.C5 (Figs 3b and c) . Two rats (one from each of the control group) that failed to develop EAU did not show any pineal inflammation either (Fig. 3a) . Pinealitis in all groups occurred as a mild to moderate sub capsular focal granuloma, frequently close to the pineal stalk. Perivasculitis was a common feature and the predominant cells were lym phocytes and monocytes. Immunocytochemi cally, CD4 cells were scattered throughout the gland (Fig. 3d ) with monocytes and CD8 cells next in frequency. A few B cells were also noted. The relative proportions of cells in inflammatory lesions was the same for all three groups of rats. Ia antigen expression was a common feature, as expected, but cells expressing interleukin 2 receptor were not observed.
Humoral response to S-antigen
Untreated and IgO treated rats which were immunised with bovine S-antigen showed a progressive increase in anti-S antibodies by ELISA between 7 and 21 days post immuni sation (Fig. 4) . Rats treated with monoclonal antibody S2.4.C5 consistently showed higher levels of anti-S antibodies in their serum than untreated or IgO treated controls (Fig. 4) . After 21 days antibody levels were maximal for all three groups.
Discussion
Modulation of the host immune response using monoclonal antibodies, although still experimental, has great potential value in the management of autoimmune diseases. The aim of this approach is to induce selective tolerance to certain antigens whilst retaining responsiveness to others. Benjamin and Waldman25 were able to induce tolerance in mice to immunogenic antigens by treatment with rat monoclonal antibodies directed against the CD4 cells.
De Kozak et al19 succeeded in inhibiting EAU in rats by the administration of mouse S-antigen specific moncolonal antibodies simultaneously with the S-antigen. They suggested that the heterologous monoclonal antibody assumed a protective role by induc ing the formation of anti-idiotypic antibodies. The mouse monoclonal afforded protection from S-antigen induced uveitis in rats probably because of the large number of antigenic determinants shared by these two species of rodents. However, the heterolog ous system that we used demonstrated that the protective role of the S-antigen specific monoclonal antibody, S2.4.C5, does not extend far across species. All the guinea pigs that received S2.4.C5 along with S-antigen developed a severe uveitis and pinealitis. The onset of uveitis was two days earlier than in the control group indicating that the monoc lonal may have in fact acted like an adjuvant. On the other hand, our homologous system using a rat monoclonal antibody in rats, was extremely effective in inhibiting EA U. Interestingly this contrasted with the obser vation that S2. 4 It is also unlikely that the monoclonal anti body could have masked antigenic epitopes on the S-antigen molecule in the rod outer segments27 thereby interfering either with its presentation to the lymphoid cells or with its interaction with effector cells since target cell responses occurred normally in the pineal gland in S2.4.C5 treated rats. An alternative explanation for the inhibitory effect of S2.4.C5 on EAU but not on EAP may lie in the requirement for effective homing mechanisms for sensitised cytotoxic lympho cytes. Whereas, in the eye a blood-retinal barrier is well defined, a blood pineal barrier does not exist.28 In EAU sensitised lympho cytes adhere to activated retinal vascular endothelium and it has been suggested that this mechanism is essential for directing lym phocyte traffic to sites of inflammation. 29 It is possible that S2.4.C5 inhibits this interaction between lymphocytes and endothelium at the blood-retinal barrier, but has no effect in the barrier-free pineal. gland where the vascular endothelium is fenestrated.3 0,3 1 The presence of relatively higher levels of antibodies during the first two weeks of immunisation in S2.4.C5 treated animals is of interest. Although the fate of the monoclonal antibody after inoculation in the rats is not known, some of this anti-S activity was prob ably due to the inoculated monoclonal anti body in the early stage. After one week it is probable that much of the injected monoc lonal antibody had been degraded or proces sed. In a heterologous system, de Kozak et apo inoculated rats with a mouse anti-S monoclonal antibody and failed to detect its presence in the sera after one week, although in the present homologous system experi ment, some of the monoclonal antibody may have persisted for longer periods. In sub sequent weeks, particularly the third and fourth weeks post-immunisation, anti-S titres were equally raised in all groups. At this stage the polyclonal host-response to S-anti gen would have predominated and was clearly not related to induction of tolerance and disease prevention as it was similar in all groups of animals.
Whatever the mechanism, it is clear that monoclonal antibody S2.4.C5 is highly effec tive in abrogating EAU and this result raises the possibility of similar strategies being adopted in human disease. There are, how ever, many problems which will have to be overcome not least of which is identifying patients with chronic intraocular inflamma tion who have clear cut evidence of autoim munity to retinal antigens. For this to be achieved we must await appropriately sensi tive tests which will differentiate 'natural' autoimmunity from pathological autoim mune phenomena.32
